Role of multiparametric magnetic resonance imaging to predict postoperative Gleason score upgrading in prostate cancer with Gleason score 3 + 4
Author:
Publisher
Springer Science and Business Media LLC
Subject
Urology
Link
https://link.springer.com/content/pdf/10.1007/s00345-020-03421-7.pdf
Reference22 articles.
1. Rawla P (2019) Epidemiology of prostate cancer. World J Oncol 10(2):63–89
2. Lee H, Lee M, Byun SS et al (2019) Evaluation of Prostate Cancer Stage Groups Updated in the 8th Edition of the American Joint Committee on Cancer Tumor-Node-Metastasis Staging Manual. Clin Genitourin Cancer 17(1):e221–e226
3. Choi MH, Jung SE, Park YH et al (2017) Multiparametric MRI of prostate cancer after biopsy: little impact of hemorrhage on tumor staging. iMRI 21:139–147
4. Offermann A, Hohensteiner S, Kuempers C et al (2017) Prognostic value of the new prostate cancer international society of urological pathology grade groups. Front Med (Lausanne) 29(4):157
5. Park J, Yoo S, Cho MC et al (2020) Patients with biopsy Gleason score 3 + 4 are not appropriate candidates for active surveillance. Urol Int 104(3–4):199–204
Cited by 7 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Risk factors for Gleason score upgrade from prostate biopsy to radical prostatectomy;Exploration of Targeted Anti-tumor Therapy;2024-07-30
2. Apparent Diffusion Coefficient as a Prognostic Indicator in Definitive Radiotherapy for Gleason Score 7 Prostate Cancer: A Retrospective Analysis;2024-07-22
3. AI-predicted mpMRI image features for the prediction of clinically significant prostate cancer;International Urology and Nephrology;2023-08-09
4. Predictive Factors for Gleason Score Upgrading in Patients with Prostate Cancer after Radical Prostatectomy: A Systematic Review and Meta-Analysis;Urologia Internationalis;2023
5. Clinicopathological factors associated with pathological upgrading from biopsy to prostatectomy in patients with ISUP grade group ≤2 prostate cancer;Asian Journal of Andrology;2022
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3